Exploring the Synergistic Effects of MOTS-c and Humanin with Senolytics

by Dr. James Ross

Disclaimer: All articles and product details provided on this website are intended for educational and informational purposes only. The products listed here are for in-vitro research only. In-vitro studies are conducted outside of living organisms. These products are not intended as medicines or drugs and have not been approved by the FDA to prevent, treat, or cure any medical condition, ailment, or disease. The direct or indirect administration of these substances to humans or animals is unequivocally prohibited under applicable law.

MOTS-c Enhances Immune Recognition of Senescent Cells

Cellular senescence plays a major role in the development of age-associated diseases. This process is typically marked by the secretion of bioactive molecules known as the senescence-associated secretory phenotype (SASP). These SASPs contribute to disease progression by sustaining cell-cycle arrest, promoting inflammation, and driving nearby cells toward either senescence or malignant transformation through paracrine signaling.

Research by Kim and colleagues revealed that MOTS-c influences the transformation of SASPs by modulating mitochondrial energy metabolism. In doing so, it exerts a cytoprotective function in aging-related disorders, alleviating senescence-related symptoms and potentially extending healthy lifespan. Similarly, Andrew and colleagues demonstrated that MOTS-c can increase the expression of SASP markers, thereby making senescent cells more visible to the immune system. Enhanced immune clearance of senescent cells protects surrounding healthy cells and contributes to overall tissue health.

Humanin and MOTS-c Elevate SASP Cytokines in Senescent Cells

In experimental work, investigators examined the effects of MOTS-c and Humanin on SASP-related cytokine production in both quiescent and senescent cells. Treatment with either peptide led to higher levels of several SASP-associated factors, including interleukins IL-6, IL-1β, IL-8, IL-10, and tumor necrosis factor alpha (TNFα).

When tested in replicatively senescent cells, both MOTS-c and Humanin also elevated SASP factor production. These findings suggest that these mitochondrial-derived peptides can selectively enhance SASP signaling in senescent contexts, potentially priming such cells for more efficient immune-mediated removal.

FOXO4-DRI Activity Strengthened Under High SASP Conditions

The FOXO4-DRI peptide, a known senolytic agent, eliminates senescent cells by interfering with p53-FOXO4 interactions. Its efficacy appears enhanced under conditions of high SASP expression. For example, in vitro assays showed that FOXO4-DRI became more potent against senescent cells when SASP levels were transiently elevated by IL-1α/β or lipopolysaccharide (LPS) stimulation. Conversely, reducing SASP activity with an IL-1 receptor antagonist or cortisol weakened its effects.

These results indicate that FOXO4-DRI preferentially targets senescent cells with strong SASP expression, making it especially effective in conditions where SASPs drive organ dysfunction such as renal decline. In animal models, FOXO4-DRI therapy normalized renal tubular IL-6 levels, restored LMNB1-positive tubular cells, and reduced plasma urea concentrations, without altering total kidney or body weight. This suggests that boosting SASP factors through MOTS-c or Humanin may create a therapeutic window where senolytics like FOXO4-DRI can function with higher efficiency.

REFERENCES

1. Baar MP, Brandt RMC, Putavet DA, Klein JDD, Derks KWJ, Bourgeois BRM, Stryeck S, Rijksen Y, van Willigenburg H, Feijtel DA, van der Pluijm I, Essers J, van Cappellen WA, van IJcken WF, Houtsmuller AB, Pothof J, de Bruin RWF, Madl T, Hoeijmakers JHJ, Campisi J, de Keizer PLJ. Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging. Cell. 2017 Mar 23;169(1):132-147.e16. doi: 10.1016/j.cell.2017.02.031. PMID: 28340339; PMCID: PMC5556182.
2. Kim SJ, Mehta HH, Wan J, Kuehnemann C, Chen J, Hu JF, Hoffman AR, Cohen P. Mitochondrial peptides modulate mitochondrial function during cellular senescence. Aging (Albany NY). 2018 Jun 10;10(6):1239-1256. doi: 10.18632/aging.101463. PMID: 29886458; PMCID: PMC6046248.

Product available for research use only: